Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research could lead to major breakthrough in the cost of effective new cancer drug

20.10.2006
Scientists at the University of Sunderland have joined forces with a US university in a new project that aims to make a miracle cancer drug affordable.

The university is jointly funding the research of PhD student Giso Abadi from Valdosta State University in Georgia, who is working with Sunderland scientists Dr Lyn Noble and Professor Paul Groundwater on the anti-cancer agent bryostatin.

In clinical trials bryostatin has already proven extremely effective in fighting many cancers, and has recently been proven effective in the treatment of Alzheimers disease. The drug is present in the marine invertebrate bugula neritina, and in the surrounding sediment in areas of the Gulf of Mexico.

However, it takes 14 tons of dry weight bugula from the ocean to extract only one ounce of purified bryostatin.

... more about:
»Cancer »bryostatin »bugula

“Mass production just isn’t viable on economic or environmental grounds using this method,” says Dr Noble, Giso’s director of studies at Sunderland.

“Usually when potential drugs which occur naturally are discovered chemists can synthesise them in the lab, and this is possible with bryostatin, but it takes 65 reaction steps. Pharmaceutical companies will only normally consider synthesising a medicinal product that uses a process of between five and ten steps, so this method also has no commercial mileage.

“It costs a kings ransom to buy synthetic bryostatin, £261 per 50 micrograms – that’s £5.2 million per gram!”

A lot of research has been done to find a cost effective way to produce the drug in the USA, including a $7m project to create a ‘sea farm’ where the marine organism could be bred naturally. Unfortunately, the farm was exposed to unpredictable weather conditions and the bugula colony was lost in a hurricane.

Now PhD student Giso is trying a different approach. Bacteria that use the marine animal as a host are thought to be responsible for producing the bryostatin.

Efforts are underway to successfully grow the bacteria in salt water tanks in the lab at Valdosta, by optimising the conditions which mimic the bacteria’s natural environment. If successful it is hoped that Giso’s methods, alongside the expertise of Sunderland chemists, will eventually find an effective and relatively inexpensive method of producing bryostatin in the laboratory.

Chemists at Sunderland were so impressed with Giso’s research that they flew out to Valdosta and convinced officials there to jointly fund her work.

Giso, who is used to the humid heat of America’s Deep South and currently trying to adjust to the North-East weather, is planning to extend her work into investigating if it’s possible to find bugula neritina and harvest it from the North Sea, rather than the Gulf of Mexico.

“Bugula is seasonal in the Gulf of Mexico, a very nondescript brown moss like animal, and it has been found in colder waters of other oceans around the world,” she said. “It’s not known if they are active in the North Sea, but the water’s certainly cold enough.”

Whether or not they do manage to find the elusive creatures in the North Sea, by optimising the growing conditions for the bacteria to thrive and produce in the lab the research team’s eventual aim is to create a ‘production line’ of bryostatin. If they can manage that the drug will be available cheaply for the first time, and will change the lives of literally millions of cancer and Alzheimer sufferers worldwide.

Tony Kerr | alfa
Further information:
http://www.sunderland.ac.uk/caffairs/septhm.htm

Further reports about: Cancer bryostatin bugula

More articles from Life Sciences:

nachricht Flow of cerebrospinal fluid regulates neural stem cell division
21.05.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Chemists at FAU successfully demonstrate imine hydrogenation with inexpensive main group metal
21.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>